- Raised grant, Apr 2016
- Raised funding round, Jan 2016
About
Access for Life aims to facilitate repetitive therapies requiring vascular access for patients with chronic diseases. The companys patented JEM device acts as a smart needle guide and is designed to preserve the vessel wall and reduce the rate of clinical complications due to vessel wall damage (e.g. perforation, pseudoaneurysms, hematomas, and infection), reducing morbidity and mortality as well as healthcare costs. The device is designed to allow for easier and safer repetitive vascular access, particularly for hemodialysis and eventually for chemotherapy. The JEM smart device attaches directly to an arterio-venous (AV) fistula or graft and is implanted in the subcutaneous tissue directly beneath the skin. It provides safer and easier repeated insertion of needles for vascular access and prevents unintended vein perforation and bleeding. The device requires much less skill for proper needle insertion, encourages home and self-care hemodialysis, and can use a blunt needle for pain reduction. It could also replace the chemoport currently used for chemotherapy. In addition, Access for Life has added sensors which allow ultrasound and velocity measurements to provide clinical data to clinicians and patients and to enable dialysis-related big data analysis.
Funding history · 2 rounds · — total
Q&A
- What is Access For Life's primary focus?
- Access For Life focuses on developing a subcutaneous implanted device for vascular access to facilitate repetitive therapies for patients with chronic diseases, particularly for hemodialysis and potentially chemotherapy.
- What is the JEM device and its purpose?
- The JEM device is a patented smart needle guide designed to preserve the vessel wall and reduce complications during repetitive vascular access. It attaches to an AV fistula or graft and is implanted subcutaneously, aiming for safer and easier needle insertion.
- When was Access For Life founded?
- Access For Life was founded in September 2013.
- How many employees does Access For Life currently have?
- Access For Life has 1-10 employees.
- What is Access For Life's current funding stage?
- Access For Life is currently in the Seed funding stage.
- Which investors participated in Access For Life's funding rounds?
- Access For Life has received funding from Pharmes Innovations Limited and a grant from EU Horizon 2020.
- What is the latest funding event for Access For Life?
- The latest funding event for Access For Life was a Grant received in April 2016 from EU Horizon 2020.
- Does Access For Life hold any patents?
- Yes, Access For Life holds one patent.
- Who is a founder of Access For Life?
- Roger Mason is a founder and CMO of Access For Life.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | accessforlife.biz |
|---|---|
| linkedin.com/company/10091723 |
Identifiers & details
| Founded | 2013-9 |
|---|---|
| Employees (exact) | 10 |
| Offices | Mount Vernon |
Radar intelligence
Patents
| EPO | 2 |
|---|
Web history (Wayback)
| Domain | accessforlife.biz |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|